OOIR: Observatory of International Research

Papers

(The TQCC of European Neuropsychopharmacology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA	150
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS	107
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER	90
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA	86
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE	85
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)	85
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK	82
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA	65
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK	64
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY	63
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS	61
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS	60
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES	51
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES	50
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS	50
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS	50
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION	48
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY	48
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE	46
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE	46
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder	46
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	45
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	42
6. DE NOVO MUTATIONS IN BIPOLAR DISORDER IMPLICATE GENES INVOLVED IN NEURODEVELOPMENT AND IMMUNITY	41
F48. INVESTIGATING POTENTIAL RELATIONSHIPS BETWEEN PIGMENTATION GENETICS AND PARKINSON'S DISEASE (PD)	39

Society Calendar	38
W101. EPIGENETIC PROFILES OF LATENT CLASSES FOR POLYSUBSTANCE USE DISORDER	38
HOW PARTICIPATING IN CAMH'S PHARMACOGENETICS IMPACT STUDY CHANGED MY LIFE	36
F7. THE ASSOCIATIONS BETWEEN EDUCATIONAL EXPERIENCES AND MENTAL HEALTH FROM CHILDHOOD TO YOUNG ADULTHOOD	34
W64. FAMILY BASED ASSOCIATION AND LINKAGE ANALYSES OF FAMILIAL ADHD	34
POLYGENIC RISK SCORES FOR PROBLEMATIC SUBSTANCE USE IN ADOLESCENTS: AN ENIGMA-ADDICTION STUDY	33
8. A CROSS-POPULATION GENOME-WIDE ASSOCIATION STUDY OF SLEEP DURATION	32
DECOLONISATION OF PSYCHIATRIC GENETICS: PERSPECTIVES FROM AN ERSTWHILE “JEWEL IN THE CROWN” COLONY	31
NOVEL LOCI AND TARGET GENES INFLUENCING FUNCTIONAL SEIZURES IDENTIFIED IN A MULTI-SITE GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS IN A SAMPLE OF 570,460 PATIENTS	31
THE ASSOCIATION BETWEEN POLYGENIC RISK FOR SCHIZOPHRENIA AND BRAIN AGE IN A POPULATION-BASED SAMPLE OF YOUNG ADULTS: A RECALL-BY-GENOTYPE-BASED APPROACH	31
GENETIC COUNSELING FOR PSYCHIATRIC CONDITIONS	30
DO POOR DIET AND LIFESTYLE BEHAVIOURS EXACERBATE THE GENETIC RISK OF IMPULSIVITY IN THE GENERAL POPULATION	30
PUMAS: POPULATIONS UNDERREPRESENTED IN MENTAL ILLNESS ASSOCIATION STUDIES PROJECT	29
T121. MULTI-OMIC NETWORK ANALYSIS IDENTIFIES KEY NEUROBIOLOGICAL PATHWAYS IN OPIOID ADDICTION	27
W87. RARE, PATHOGENIC COPY NUMBER VARIANTS CO-SEGREGATE WITH SCHIZOPHRENIA IN PEDIGREE COHORT	26
DIFFERENTIAL ISOFORM USAGE IN SCHIZOPHRENIA	25
25. EPIGENOME-WIDE META-ANALYSIS OF > 3200 MILITARY AND CIVILIAN PARTICIPANTS IDENTIFIES CELL-TYPE SPECIFIC DNA METHYLATION SIGNALS ASSOCIATED WITH PTSD	25
F94. SIGNIFICANT TELOMERE SHORTENING IN MALAYSIAN PATIENTS WITH SCHIZOPHRENIA: RELATIONSHIP WITH TOTAL ANTIOXIDANT CAPACITY AND OTHER COVARIATES	25
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES	24
ECNP Calendar of Meetings	24
Editorial Board	24
T70. A COMPUTATIONAL TRANSCRIPTOMICS APPROACH TO DRUG REPURPOSING IDENTIFIES NEW THERAPEUTIC CANDIDATES FOR TREATMENT OF CHRONIC PAIN	24
BEYOND STANDARD GWAS IN BIPOLAR DISORDER: INTEGRATIVE FINE-MAPPING, MULTI-TRAIT, AND EPIGENETIC APPROACHES FOR CAUSAL VARIANT DISCOVERY	23
T39. POLYGENIC RISK AND CHILDHOOD TRAUMA AS PREDICTORS OF SUICIDE RISK IN BIPOLAR DISORDER	23
W2. MULTIVARIABLE GENE ENVIRONMENT INTERACTION IN THE PREDICTION OF PROSOCIAL BEHAVIOR	23
M70. INTRODUCTION TO THE MOUNT SINAI MILLION SCHIZOPHRENIA DISCOVERIES PROGRAM (MSM-SCZ)	23
M74. RE-EVALUATING THE ROLE OF 22Q11 DELETION SYNDROME (22Q11DS) IN SCHIZOPHRENIA	22
W87. PREDICTORS OF ALCOHOL CONSUMPTION: THE ROLE OF GENETICS AND IMPULSIVITY FROM ADOLESCENCE TO ADULTHOOD	22
ELECTRONIC HEALTH RECORDS AND BIOBANKS IN THE ERA OF COMPUTATIONAL AND GENOMIC PSYCHIATRY	22
T33. MULTI-OMICS MACHINE LEARNING APPROACHES TO ELUCIDATE BIOLOGICAL SIGNATURES OF DEPRESSION: INSIGHTS FROM THE UK BIOBANK	22
W47. THE GENETIC ARCHITECTURE OF DIFFICULT-TO-TREAT DEPRESSION: A PHARMLINES INITIATIVE COHORT STUDY	21
W17. CONCORDANT AND DISCORDANT GENETIC VARIANTS ASSOCIATED WITH MENTAL ILL-HEALTH AND THEIR IMPACT ON CARDIOMETABOLIC RISK	21
3. MODELING AGE-DEPENDENT GENETIC EFFECTS ON TEMPERAMENT AND MENTAL HEALTH	21
Exploring the link between functional connectivity of ventral tegmental area and physical fitness in schizophrenia and healthy controls	20
The association of CNR1 genetic variants with resting-state functional connectivity in youth bipolar disorder	20
87. ATLAS OF PHENOTYPE-GENOTYPE RELATIONSHIPS BETWEEN PLASMA METABOLIC MARKERS, BRAIN MORPHOLOGY AND PSYCHIATRIC DISORDERS	20
Stress, mental disorder and ketamine as a novel, rapid acting treatment	19
The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders	19
Are cell type-specific methylation profiles the missing link in ADHD epigenetics?	19
Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment	18
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	18
Editorial Board	18
17. LANDSCAPE SURVEY OF 8853 CLINICAL TRIALS IN DEPRESSION TO IDENTIFY NEW TREATMENT RESPONSE PHARMACOGENETIC STUDIES	18
T8. TREATMENT WITH GALANTAMINE IN 15Q13.3 DELETIONS: GENOMICALLY-INFORMED PRECISION MEDICINE STRATEGIES IN NEURODEVELOPMENTAL DISORDERS	18
Muscle and the mind: The combination of creatine and exercise for depression	18
Editorial Board	18
T3. DEPRESSION ASSOCIATED GENETIC, TRANSCRIPTOMIC AND PATHWAY -LEVEL PROFILING OF TRAUMA-EXPOSED MILITARY AND CIVILIAN COHORTS	17
Editorial Board	17
T71. GENETIC AND ENVIRONMENTAL ASSOCIATION BETWEEN PRESENT MOMENT ATTENTION AND SUBJECTIVE WELLBEING	17
W38. INVESTIGATION OF GENE-ENVIRONMENT INTERACTIONS BETWEEN GENETICALLY REGULATED GLUCOCORTICOID REACTIVITY AND STRESSFUL LIFE EVENTS IN MAJOR DEPRESSIVE DISORDER	17

T75. ASSOCIATIONS BETWEEN POLYGENIC RISK SCORE FOR SCHIZOPHRENIA AND SCHIZOTYPAL TRAITS IN THE MULTIPLEX FAMILIES OF PATIENTS WITH SCHIZOPHRENIA	17
W31. KETAMINE AND ELECTROCONVULSIVE THERAPY DEPRESSION TREATMENTS ALTER ISOFORM- AND CELL TYPE-SPECIFIC TRANSCRIPTOMES IN THE MOUSE PREFRONTAL FRONTAL CORTEX	17
F10. TRACES OF ASSORTATIVE MATING FOR MENTAL DISORDERS IN THE HUMAN GENOME	16
W17. REGIONAL GENETIC ARCHITECTURE OF THE CORPUS CALLOSUM AND ITS OVERLAP WITH PSYCHIATRIC AND SUBSTANCE USE PHENOTYPES	16
INNOVATING KNOWLEDGE DISSEMINATION FOR CULTURAL RELEVANCE AND ACCESSIBILITY	16
LONGITUDINAL GENETIC APPROACHES IN MENTAL HEALTH: INTERNATIONAL PERSPECTIVES AND OPPORTUNITIES	16
F59. DISENTANGLING THE OVERLAP BETWEEN SUICIDE ATTEMPT AND ASSOCIATED PHENOTYPES USING LOCAL GENETIC CORRELATIONS	16
ABSENCE OF NONFATAL SUICIDAL BEHAVIOR PRECEDING SUICIDE DEATH REVEALS CLINICAL AND GENETIC RISK DIFFERENCES	16
75. GWAS IDENTIFIES NOVEL LOCI ASSOCIATED WITH SPECIFIERS OF BIPOLAR DISORDER	16
F99. GENETIC CORRELATION OF CHILDHOOD AGGRESSION WITH MENTAL AND GENERAL HEALTH TRAITS	16
20. PHENOME-WIDE ASSOCIATION STUDY OF COGNITIVE FUNCTION IN MULTIETHNIC ASIAN POPULATION	16
87. RS148582811 REGULATES ITS HOST GENE ARVCF EXPRESSION TO AFFECT NICOTINE-ASSOCIATED HIPPOCAMPUS-DEPENDENT MEMORY	16
46. PATHWAY-BASED POLYGENIC RISK SCORES USING MACHINE LEARNING: APPLICATION TO SCHIZOPHRENIA AND BIPOLAR DISORDER	15
PRS PREDICTION BEYOND FAMILY HISTORY	15
DECODING CELL TYPE-SPECIFICITY THROUGH SYSTEMATIC CELL TYPE ANNOTATIONS OF SINGLE-CELL RNA SEQUENCING DATA AMONG TISSUES AND APPLICATION TO PSYCHIATRIC DISORDERS AND OTHER TRAITS	15
W9. IDENTIFYING CENTRAL AND TRANS-DIAGNOSTIC PSYCHIATRIC SYMPTOMS COMBINING NETWORK ANALYSIS AND GENETICS	15
54. EXAMINING COMMON AND SPECIFIC GENETIC INFLUENCES ON SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION	15
PRESENTING A MULTIDISCIPLINARY FRAMEWORK FOR RESEARCH GENOME SEQUENCING COUPLED WITH GENETIC COUNSELING AND RETURN OF CLINICALLY VALIDATED PRIMARY AND SECONDARY FINDINGS FOR INDIVIDUALS WITH PSYCHIATR	15
T68. DDR1 PROMOTER METHYLATION IN DIFFERENT PSYCHIATRIC DISORDERS AND ITS RELATIONSHIP TO NEUTROPHIL-TO-LYMPHOCYTE RATIOS	15
W32. A GENOME-WIDE ASSOCIATION STUDY OF BIPOLAR DISORDER FROM INDIA	15
MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDIES PROVIDE NOVEL BIOLOGICAL INSIGHTS INTO THE GENETIC ARCHITECTURE OF BIPOLAR DISORDER	15
TREML2 IN THE CONTEXT OF WHITE MATTER HYPERINTENSITIES AND ALZHEIMER'S DISEASE	15
BEYOND BORDERS: INTEGRATING TRAINING AND RESEARCH FOR SCIENTIFIC EXCELLENCE AND GLOBAL EQUITY	14
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD coh	14
F11. PATTERNS OF GENETIC OVERLAP BETWEEN BIPOLAR DISORDER, SUBSTANCE USE DISORDERS AND SUBSTANCE CONSUMPTION PHENOTYPES REVEAL DISTINCT FACTORS OF PATHOLOGY	14
W12. BIDIRECTIONAL CROSS-TRAIT GENETIC NURTURE BETWEEN INTERNALIZING AND SUBSTANCE USE DOMAINS	14
WHOLE EXOME SEQUENCING IN AN AUTISM MULTIPLEX FAMILY OF INDIAN ORIGIN REVEALS INCREASED GENETIC BURDEN OF MATERNALLY TRANSMITTED VARIANTS	14
Letter to the editor concerning: “Antipsychotic drug dosing and study discontinuation in schizophrenia: A systematic review and dose-response meta-analysis”	14
Number needed to treat and number needed to harm: What are they good for?	14
Prader Willi syndrome, its psychiatric implications and their possible biological basis	14
Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)	14
F93. CELL-TYPE SPECIFIC TRANSCRIPTOMIC PROFILING IN SCHIZOPHRENIA IDENTIFIES CHANGES IN GABAERGIC NEURONS AND OLIGODENDROCYTES AT TRANSCRIPT LEVEL	14
POPULATION MEDICAL GENOMICS IN LATIN AMERICA	13
W88. GENETICALLY FASTER CYP2A6-MEDIATED NICOTINE METABOLISM INCREASES SMOKING-RELATED DISEASE RISK: A PHENOME-WIDE ASSOCIATION STUDY IN THE ALL OF US RESEARCH PROGRAM	13
INSIGHTS INTO THE METABOLIC ORIGINS OF ANOREXIA NERVOSA THROUGH GENOMICS AND NEUROIMAGING	13
W1. CAN RESPONSE TO PSYCHOTHERAPY IN OBSESSIVE-COMPULSIVE DISORDER BE PREDICTED FROM DNA METHYLATION DATA?	13
M21. POLYGENICITY OF ANOREXIA NERVOSA AT THE PATHWAY LEVEL	13
W54. DETECTION OF DIFFERENTIALLY EXPRESSED GENES IN IPSC-DERIVED TROPHOBLAST CULTURES FROM CONTROLS AND PATIENTS WITH SCHIZOPHRENIA	13
16. HOW DO PATIENTS WITH MAJOR DEPRESSION RESPOND TO DOSAGE INCREMENTS OF ANTIDEPRESSANTS? A CLINICAL AND GENETIC INVESTIGATION IN UK BIOBANK	13
AN INTERNATIONAL, CASE-CASE META-ANALYSIS OF TREATMENT RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	13
THE ROLE OF SEX IN POLYGENIC RISK FOR SEX-BIASED BRAIN DISORDERS	13
Psychopathology for the twenty-first century: Towards a ChatGPT psychopathology?	12
M45. OPEN BOARD	12
T62. EXPLORING THE LANDSCAPE OF GENETIC TESTING FOR AUTISM: PERSPECTIVES FROM AUTISTIC INDIVIDUALS, FAMILIES, AND PHYSICIANS AND TRENDS IN HEALTHCARE DATA IN ALBERTA, CANADA	12
Antidepressant use in pregnancy and neonatal outcomes: reassuring findings from an asian cohort	12
M25. POLYGENIC RISKS AND CARDIOVASCULAR TREATMENT EFFECTS IN SEVERE MENTAL ILLNESS	12
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.	12
POLYGENIC SCORE OF POST-TRAUMATIC STRESS DISORDER HIGHLIGHTS ASSOCIATION WITH CARDIOVASCULAR DISORDERS IN ELECTRONIC HEALTH RECORDS OF >94,000 INDIVIDUALS	12
SLEEP INERTIA DRIVES THE ASSOCIATION OF EVENING CHRONOTYPE WITH PSYCHIATRIC DISORDERS: GENETIC AND EPIDEMIOLOGICAL EVIDENCE	12
W66. NEUROBIOLOGICAL CORRELATES OF MALE SEXUAL ORIENTATION	12
F3. METABOLIC EFFECT OF CYP2C19 AND CYP2D6 ON ANTIDEPRESSANT RESPONSE: A META-ANALYSIS OF 13 DEPRESSION PHARMACOGENETIC STUDIES	11
W14. EXPLORING THE RELATIONSHIP BETWEEN GENETIC PREDISPOSITION TO MENTAL HEALTH DISORDERS AND THE SOCIAL ENVIRONMENT IN THE UK BIOBANK	11
EXOME SEQUENCING TECHNOLOGY AND ANALYSIS	11
ECNP Calendar of Meetings	11
Serotonin 5-HT2A receptors in schizophrenia: Reflexions on an unfinished story	11
T95. ITERATING TOWARDS PRECISION PHENOTYPING OF SCHIZOPHRENIA IN THE ELECTRONIC HEALTH RECORD	11
86. AN INTERNATIONAL, CASE-CASE MEGA-ANALYSIS OF TREATMENT-RESISTANT SCHIZOPHRENIA VERSUS NON-TREATMENT RESISTANT SCHIZOPHRENIA	11
32. PRINCIPAL AND INDEPENDENT GENOMIC COMPONENTS OF BRAIN STRUCTURE AND FUNCTION: ROBUSTNESS AND RELEVANCE	11
W35. INVESTIGATION OF RELATIONSHIPS BETWEEN INTERNALIZING, EXTERNALIZING, AND RISKY SEXUAL BEHAVIOR: A GENETICALLY-INFORMATIVE SAMPLE	11
T23. ASSOCIATION OF CHILDHOOD TRAUMA EXPOSURE WITH DDR1 PROMOTER METHYLATION IN BIPOLAR DISORDER	10
As in cooking, so in medicine: Doses do matter	10
73. IMPACT OF GENETIC RISK VARIANTS OF MENTAL DISORDERS ON EPIGENETIC REGULATION: AN MQTL APPROACH	10
A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood	10
Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence	10
Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trial	10
W44. UNVEILING GENETIC ARCHITECTURES FOR STRATIFYING TRAJECTORIES OF ADOLESCENT DEPRESSION	10
GENOMIC STRUCTURAL EQUATION MODELING APPLIED TO 14 MAJOR PSYCHIATRIC DISORDERS	10
W6. INTERACTION BETWEEN BDNF METHYLATION, SUICIDAL IDEATION, AND LONG-TERM OUTCOMES AFTER STROKE	10
PHARMACOGENETICS OF ANXIETY AND OBSESSIVE-COMPULSIVE DISORDERS	10
Associations between individual depressive symptoms and immunometabolic characteristics in major depression	10
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	10
Cell type-specific methylome-wide association studies of childhood ADHD symptoms	10
T65. GENES IN POSTMORTEM BRAIN TISSUE DIFFERENTIALLY EXPRESSED IN CHRONIC PAIN	10
W97. A GENOMEWIDE ASSOCIATION STUDY OF ANTIPSYCHOTIC INDUCED EXTRAPYRAMIDAL SIDE EFFECTS	10
ASSESSING THE UTILITY OF PHARMACOGENETIC TESTING IN A COHORT WITH TREATMENT-RESISTANT SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER	10
Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years	10
Exploring the incidence of inadequate response to antidepressants in the primary care of depression	10
Biomarker innovations in precision psychiatry diagnostics and treatment strategies	10
How else can inflammation kill you?	9
W76. CONFIRMATORY FACTOR ANALYSES OF PSYCHOSIS SYMPTOMS EXHIBIT MEASUREMENT NONINVARIANCE ACROSS CLINICAL PHASE OF ILLNESS IN SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER, AND BIPOLAR I DISORDER	9

METHODS FOR UNDERSTANDING GENETIC CONTRIBUTIONS TO LIFECOURSE MENTAL DISORDERS	9
83. CHARACTERIZING BIOPSYCHOSOCIAL FACTORS AND RELATIONSHIPS WITH CLINICAL TRAITS FOR PSYCHOTIC-LIKE EXPERIENCES IN ADOLESCENTS	9
MODELING MATERNAL INFLAMMATION AND NEURODEVELOPMENT-RELEVANT ENDPOINTS IN BRAIN ORGANOIDS	9
33. GENETIC REGULATION OF HUMAN BRAIN RNA EDITING IN EAST ASIAN	9
Predicting 10-year risk of chronic kidney disease in lithium-treated patients with bipolar disorder: A risk model development and internal cross-validation study	9
EVALUATING THE CAUSAL RELATIONSHIP BETWEEN EDUCATIONAL ATTAINMENT AND MENTAL HEALTH	9
REMOVING PLEIOTROPIC SIGNALS REVEAL DISEASE-SPECIFIC GENETIC ARCHITECTURE IN NOISY, SHALLOW BIOBANK PHENOTYPES	9
SHARED CARDIOVASCULAR RISK FACTORS AND GENETIC OVERLAP OF POSTPARTUM DEPRESSION AND MAJOR DEPRESSIVE DISORDER	9
75. MIR1255A REGULATES PATHWAYS CRITICAL FOR BRAIN DEVELOPMENT, RISK GENES FOR DEPRESSION AND NEURODEVELOPMENTAL DISORDERS	9
The genetics of treatment-resistant depression: controversies and perspectives	9
T86. GENOME-WIDE ASSOCIATION STUDY OF IRRITABILITY FOLLOWING SMOKING CESSATION IN A CLINICAL TRIAL	9
RARE CODING VARIANTS IN 195,257 INDIVIDUALS REVEAL 29 NOVEL BIPOLAR DISORDER GENES AND STRUCTURAL MISSENSE HOTSPOTS IN PROTEIN SPACE	9
COMBINING GENETIC AND NEUROIMAGING RISK SCORES FOR THE PREDICTION OF PSYCHIATRIC DISORDERS	9
T37. GENOME-WIDE ASSOCIATION STUDY (GWAS) OF ANTIDEPRESSANT TREATMENT RESPONSE IN MAJOR DEPRESSIVE DISORDER IN JAPANESE POPULATION	9
T4. SHARED GENETIC RISK FACTORS CONTRIBUTE TO THE RELATIONSHIP BETWEEN NAUSEA AND VOMITING IN PREGNANCY AND MENTAL HEALTH CONDITIONS	9
HOW DO WE MAKE POLYGENIC RISK SCORES (PRS) UNDERSTANDABLE? THE DEVELOPMENT AND EVALUATION OF A NEW TOOL TO ACCOMPANY PRS	8
94. AN INDUCED PLURIPOTENT STEM CELL (IPSC) RESOURCE FROM GENETICALLY ISOLATED FAMILIES WITH NEUROPSYCHIATRIC DISORDERS	8
T54. FIRST GWAS ON AFFECTIVE TEMPERAMENTS IDENTIFIES NOVEL GENOME-WIDE SIGNIFICANT VARIANT FOR ANXIOUS TEMPERAMENT AND SUGGESTIVE VARIANTS FOR ALL FIVE AFFECTIVE TEMPERAMENTS	8
INTEGRATING POLYGENIC RISK SCORES WITHIN TWIN MODELLING TO INVESTIGATE THE CAUSAL RISK FACTORS FOR SELF-HARM	8
Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis	8
F80. A DNA METHYLATION STUDY OF COMMON AND SPECIFIC TREATMENT EFFECTS OF THREE ANTIPSYCHOTICS IN THE TREATMENT OF PSYCHOSIS	8
13. DISTINGUISHING DIFFERENT PSYCHIATRIC DISORDERS USING DDX-PRS	8
MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF PTSD, ALCOHOL USE AND ALCOHOL USE DISORDERS	8
T28. EXPLORING THE RELATIONSHIP BETWEEN ACNE AND MENTAL HEALTH DISORDERS	8
AN ONTOLOGICAL BASED APPROACH TO CHARACTERIZE THE BEHAVIORAL DIFFERENCES BETWEEN PATIENTS WITH 16P11.2 DUPLICATION AND DELETION	8
MERGING THE BOUNDARIES BETWEEN THE BRAIN AND THE HEART: UNDERSTANDING THE SHARED BIOLOGY OF MOOD DISORDERS AND CARDIO-METABOLIC PHENOTYPES USING GENETICS, GENOMICS AND ELECTRONIC HEALTH RECORD DATA	8
EXPANDING OUR UNDERSTANDING OF GENETIC RISK FOR BINGE EATING VIA A GENOME-WIDE ASSOCIATION STUDY	8
F39. CONTRIBUTION OF COMMON POLYGENIC VARIATION TO THERAPY RESPONSE IN THE EARLY MEDICATION CHANGE COHORT	8
GENOME-WIDE ASSOCIATION STUDIES OF ANOREXIA NERVOSA: AN OVERVIEW, UPDATE, AND IMPLICATIONS	8
GENOME-WIDE GENE-GENE INTERACTION OF THE 5-HTTLPR PROMOTER POLYMORPHISM EMPHASIZES THE IMPORTANT ROLE OF NEUROPLASTICITY IN DEPRESSION	8
PERCEPTIONS OF CAUSAL ATTRIBUTION AND ATTITUDES TO GENETIC TESTING AMONG PEOPLE WITH SCHIZOPHRENIA AND THEIR FIRST-DEGREE RELATIVES	8
T85. INVESTIGATING THE GENETIC ARCHITECTURE OF REGIONAL BRAIN STRUCTURE AND ITS RELATIONSHIP TO SCHIZOPHRENIA	8
F59. DISSECTING THE CONTRIBUTIONS OF RARE AND COMMON GENETIC VARIATION TO NEURODEVELOPMENTAL OUTCOMES	8
F44. DIFFERENCES IN POLYGENIC RISK SCORE FOR MAJOR DEPRESSIVE DISORDER DEPENDING ON CASE DEFINITION IN AN ELECTRONIC HEALTH RECORDS STUDY	8
41. USING BRAIN CELL-TYPE-SPECIFIC INTERACTOMES OF PROTEINS ENCODED BY RISK GENES TO UNCOVER BIOLOGY UNDERLYING SCHIZOPHRENIA AND RELATED DISORDERS	8
CONTRIBUTION OF GENOME SEQUENCING IN THE EVALUATION OF CHILDREN AND ADOLESCENTS WITH SUSPECTED SERONEGATIVE AUTOIMMUNE ENCEPHALITIS	7
26. UNRAVELING THE HETEROGENEITY OF PTSD SYMPTOMS THROUGH IDENTIFYING EPIGENETIC SUBTYPES AMONG TRAUMA-EXPOSED CIVILIAN WOMEN	7
PRELIMINARY RESULTS FROM THE FIRST SPANISH GWAS ON DEPRESSION IN THE EPIDEMIOLOGICAL PISMA-EP STUDY.	7
VARIANCE QUANTITATIVE TRAIT LOCI MAPPING IN THE MOBA COHORT: DETECTING INTERACTION EFFECTS INVOLVED IN DEVELOPMENTAL OUTCOMES	7
F57. INVESTIGATION OF THE SEX CHROMOSOMES IN AUTISM SPECTRUM DISORDER	7
IMMUNO-PSYCHIATRY AND INFLAMMATION	7
W23. GENOME-WIDE ASSOCIATION STUDY OF UNCONTROLLED EATING	7
F73. CLINICAL AND GENETIC TRAUMA-RELATED RISK FACTORS LEADING TO SUICIDE DEATH	7
57. TRANSCRIPTOMIC DYSFUNCTION DISPARITIES: GREATER BURDEN IN FEMALE BRAINS HIGHLIGHTS IMMUNE AND SYNAPTIC PATHWAYS FOR PSYCHIATRIC DISORDERS	7
CHARACTERIZING THE LOCAL GENETIC CORRELATIONS BETWEEN 14 MAJOR PSYCHIATRIC DISORDERS	7
THE GENETIC ARCHITECTURE OF BEAT SYNCHRONIZATION THROUGH A NEURODEVELOPMENTAL AND NEURO-FUNCTIONAL LENS	7
Response to the letter regarding “Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach”	7
WHOLE GENOME SEQUENCING	7
THE IMPACT OF EARLY ADVERSITY AND EDUCATIONAL ATTAINMENT ON GENETIC AND BRAIN MORPHOLOGICAL PREDICTORS OF INTELLIGENCE	7
W85. EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF THE UBACC QUESTIONNAIRE IN ASSESSING CAPACITY TO CONSENT IN DIVERSE AFRICAN POPULATIONS	7
T82. ASSOCIATION OF SCHIZOPHRENIA POLYGENIC RISK SCORES WITH TREATMENT-RESISTANT SCHIZOPHRENIA	7
Assessing risk for bipolar disorder. Comments on ``Young people at risk for developing bipolar disorder: Two-year findings from the multicenter prospective, naturalistic Early-BipoLife study'' (Martin	7
I WOULDN'T TREAT A [POLYGENIC RISK] SCORE WITH PILLS	7
Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker	7
W91. FAMILY BASED GENOME-WIDE ASSOCIATION ANALYSIS OF NOVELTY SEEKING IN A KOREAN SCHIZOPHRENIC POPULATION: A PILOT STUDY	6
CONTRIBUTION OF POLYGENIC SCORES FOR A “COMMON EXECUTIVE FUNCTION” FACTOR TO COGNITIVE PERFORMANCE IN THE PSYCOURSE STUDY	6
JOINT MULTI-FAMILY HISTORY AND MULTI-POLYGENIC SCORE PREDICTION OF MAJOR DEPRESSIVE DISORDER	6
NEURONAL-SPECIFIC METHYLOME AND HYDROXYMETHYLOME ANALYSIS IDENTIFIES NOVEL LOCI ASSOCIATED WITH ALCOHOL USE DISORDER	6
FUNCTIONAL GENOMIC APPROACHES WITH SINGLE-CELL RESOLUTION PROVIDE MECHANISTIC AND BIOLOGICAL INSIGHTS BASED ON GENETIC ASSOCIATION STUDIES	6
T72. RISK LOCI ASSOCIATED WITH INTERNET GAMING DISORDER IN ADOLESCENT: A GENOME-WIDE ASSOCIATION STUDY	6
CURRENT CHALLENGES AND OPPORTUNITIES IN DATA-DRIVEN APPROACHES IN NEUROPSYCHIATRIC DISORDERS	6
T60. GENETIC CORRELATES OF AGE AT AUTISM DIAGNOSIS IS ASSOCIATED WITH VARYING MENTAL HEALTH AND DEVELOPMENTAL PROFILES, AND HETEROGENEITY IN AUTISM	6
Traumatic loss, bereavement, and prolonged grief disorder in times of war: insights from Ukraine	6
The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses	6
Immuno-psychiatry: Dreams or reality?	6
SYSTEMS BIOLOGY OF PTSD REVEALS MECHANISMS OF RISK AND DISEASE PROCESSES AT BRAIN MULTI-OMIC, BRAIN CELL TYPE, AND BLOOD LEVELS	6
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance	6
PHARMACOGENETIC INFORMED PRESCRIBING FOR MAJOR DEPRESSIVE DISORDER	6
Disease continuum centered on Parkinson's disease	6
F52. DNA METHYLATION AT BIRTH AS POTENTIAL MEDIATOR BETWEEN PARENTAL FACTORS AND CHILD ATTENTION DEFICIT HYPERACTIVITY DISORDER – A GENETICALLY INFORMED PROSPECTIVE COHORT STUDY	6
T56. NEONATAL BLOOD TRANSCRIPTOMICS REVEAL EXPRESSION SIGNATURES OF ADHD RISK	6
W71. LONGITUDINAL BIOPSYCHOSOCIAL MARKERS OF POSTTRAUMATIC OUTCOMES IN A DIVERSE GROUP OF EMERGENCY RESPONDERS	6
66. INTEGRATED SINGLE-CELL MULTIOMIC PROFILING OF CAUDATE NUCLEUS SUGGESTS KEY MECHANISMS IN ALCOHOL USE DISORDER	6
Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice	6
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data	6
11. GENETIC EPIDEMIOLOGY AND POLYGENICITY OF PSYCHOTIC MAJOR DEPRESSIVE DISORDER	6
W98. GENETIC ARCHITECTURE AND POLYGENIC PREDICTION OF ALCOHOL USE DISORDER IN NEPAL	6
Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens	6
T91. IL-3RA (RS 6603272 G/T) GENE POLYMORPHISM IN THE BATAKNESE POPULATION WITH SCHIZOPHRENIA AND ITS CORRELATION TO NEGATIVE SYMPTOMS	6
62. INVESTIGATING THE FAMILIAL CO-AGGREGATION OF PSYCHIATRIC, SOMATIC, AND BEHAVIORAL OUTCOMES WITH BORDERLINE PERSONALITY DISORDER IN A SWEDISH BIRTH COHORT: SHARED GENETIC OR ENVIRONMENTAL FACTORS?	6
51. GENETIC NURTURE EFFECTS IN DEPRESSIVE AND ANXIETY DISORDERS AND SYMPTOMS, AND IN RELATED TRAITS	6
PRELIMINARY INVESTIGATIONS INTO THE GUT MICROBIOME'S ROLE IN SCHIZOPHRENIA	6
FINE-MAPPING ACROSS DIVERSE ANCESTRIES DRIVES THE DISCOVERY OF PUTATIVE CAUSAL VARIANTS UNDERLYING HUMAN COMPLEX TRAITS AND DISEASES	6
Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)	6
W20. COMBINING GENETIC, QUESTIONNAIRE AND ROUTINELY-COLLECTED DATA: THE SHARE MENTAL HEALTH COHORT	5
QUANTIFYING POLYGENIC OVERLAP ACROSS 14 MAJOR PSYCHIATRIC DISORDERS WITH MIXER	5
THE JOINT PHENOTYPIC AND MOLECULAR GENETIC ARCHITECTURE OF ANXIETY DISORDERS AND MAJOR DEPRESSIVE DISORDER	5
68. DISCOVERING GENES LINKED TO BOTH COGNITION AND PSYCHIATRIC DISORDERS THROUGH ANALYSIS OF 888,052 EXOMES	5
Foundations for safer evidence-based digital health technologies under construction	5
METHYLOME-WIDE ASSOCIATION STUDY OF ANXIETY DISORDERS	5
NOVEL APPROACHES TO SYSTEM-LEVEL BRAIN FUNCTION FROM ASSEMBLY INSTRUCTIONS TO MENTAL HEALTH	5
15. CONTROLLING FOR THE GENERAL PSYCHOPATHOLOGY FACTOR P IN GENOMIC RESEARCH ON PSYCHIATRIC DISORDERS (PART 1)	5
50. IDENTIFICATION OF DEPRESSION-RELATED METABOLIC PROFILE AND ITS ASSOCIATIONS WITH PSYCHIATRIC SYMPTOMS AND POLYGENIC SCORES	5
T119. AN INTERNATIONAL AND MULTI-ANCESTRAL GENOME-WIDE ASSOCIATION STUDY META-ANALYSIS OF CANNABIS USE DISORDERS	5
F19. OPEN BOARD	5